Biodistribution and dosimetry of [18F]fluorodeoxyglucose labelled leukocytes in normal human subjects
Biodistribution and dosimetry of [18F]fluorodeoxyglucose labelled leukocytes in normal human subjects
复制标题
DOI:
10.1097/00006231-200208000-00004
复制
发表时间:
2002-08-01
影响因子:
1.5
通讯作者:
Thorson, LM
中科院分区:
文献类型:
--
作者:
Forstrom, LA;Dunn, WL;Thorson, LM
This study was performed in order to assess [F-18]fluorodeoxyglucose white blood cell (F-18-FDG WBC) dosimetry in normal human subjects. Using previously reported methods, mixed cell suspensions of autologous leukocytes were prepared from four normal volunteers. Leukocytes were labelled in heparin-saline by incubation with F-18-FDG at 37degreesC for 20 min. After washing and resuspension, F-18-FDG WBCs (225-315 MBq) were administered by intravenous injection. Whole-body imaging was performed at 0.5, 1, 2,4 and 6 h using a GE Varicam with 511 keV collimation. Blood samples were obtained at corresponding times as well as fractionated urinary collection. Whole-body anterior and posterior images were used for calculation of organ dosimetry. Uptake of F-18-FDG WBCs occurred predominantly within the reticuloendothelial system. Plasma activity, urinary excretion (9.9+/-2.3% at 6 h), and brain uptake (1.7+/-0.4%) were consistent with partial elution of F-18-FDG. Positron emission tomography imaging performed at 5-6 h after injection yielded good quality images of reticulo-endothelial uptake. Whole-body and organ dosimetry for F-18-FDG WBCs in doses of 225-250 MBq are comparable with reported results for conventional doses of In-111 oxine labelled leukocytes. Further studies of 18F-FDG WBC as an agent for positron emission tomography imaging of inflammatory disease appear warranted. ((C) 2002 Lippincott Williams Wilkins).